Andrew P. Dervan, MD, MBA, is a physician specializing in medical genetics and internal medicine, with expertise in cancer genetics. He serves as Assistant Professor of Medicine and Medical Genetics at the University of Washington School of Medicine and as an attending clinical geneticist at the Genetic Medicine Clinic at UW Medical Center–Montlake. His clinical practice focuses on adult clinical genetics, cancer genetics, and precision genomic medicine. Dr. Dervan’s research interests center on computational human genetics and multi-omics discovery in neuroscience, translational oncology and functional genomics, and health policy related to genomic diagnostics. He is co-founder and co-chief executive officer of Cajal Neuroscience, reflecting his leadership at the intersection of academic medicine and biotechnology, and previously held senior business development and translational medicine leadership roles at Celgene and Bristol Myers Squibb. He earned his MD from Harvard Medical School and his MBA from Harvard Business School. He completed a general internal medicine internship and internal medicine residency at the University of Washington, followed by residency and fellowship training in medical genetics at the University of Washington.
Assistant Professor
Medical School
2005 – 2011
Residency
2011 – 2012